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The morphology of crystals has an appreciable impact
role on the physicochemical properties of drugs. Drug
properties such as flowability, dissolution, hardness and
bioavailability may be affected by crystallinity behaviours
of drugs. The objective of this study was to achieve an
improved physicomechanical property of carbamazepi-
ne powder through recrystallization from aqueous solu-
tions at different pH values. For this purpose, carbama-
zapine was recrystallized from aqueous solutions at
different pH values (1, 7, 11). The morphology of crystals
was investigated using scanning electron microscopy; X-ray
powder diffraction (XRPD) was used to identify polymor-
phism; thermodynamic properties were analyzed using
differential scanning calorimetery (DSC). Dissolution ra-
te was determined using USP dissolution apparatus. Me-
chanical behavior of recrystallized carbamazepine pow-
ders was investigated by making tablets under different
compaction pressure and measuring their hardness. SEM
studies showed that the carbamazepine crystallization in
different media affected the morphology and size of car-
bamazepine crystals. The shape of carbamazepine crys-
tals changed from flaky or thin plate-like to needle shape.
XRPD and DSC results ruled out any crystallinity changes
occurring due to the temperature during recrystallization
procedure or pH of crystallization media. The crushing
strength of tablets indicated that all of the recrystallized
carbamazepine samples had better compactiblity than the
original carbamazepine powder. In vitro dissolution stu-
dies of carbamazepine samples showed a higher dissolu-
tion rate for carbamazepine crystals obtained from media
with pH 11 and 1. Carbamazepine particles recrystallized
from aqueous solutions of different pH values (all media)
appeared to have superior mechanical properties to those
of the original carbamazepine sample.
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Solid-state forms exhibit variable physicochemical and physicomechanical (related
to mechanical behavior) properties that affect their processing and product performance.
These properties can be classified as fundamental and derived properties. The shape af-
fects the flow and packing properties of a powder, having some influence on the surface
area as well. The surface area per mass unit or volume is an important characteristic of a
powder when undertaking surface adsorption and dissolution rate studies. According to
the classic dissolution equation of Noyes and Whitney (1), the dissolution rate of a drug
is directly proportional to its surface area available for dissolution. This fact could be
used to enhance the dissolution rate of water-insoluble drugs. Many substances have the
ability to crystallize in more than one crystalline form. Although they are chemically iden-
tical, there can be significant differences in their physicochemical properties. Tableting
characteristics, flow dissolution profile as well as physicochemical stability of the drug
during storage could be affected by different crystalline forms of the drug. Also the mor-
phology of crystals has a considerable effect on the physicochemical properties of drugs.
The crystallization technique can change the habit-crystal form and particle size. The na-
ture and extent of these changes depend on the crystallization conditions such as type of
crystallization medium (2).
Carbamazepine, a drug used routinely in the treatment of epilepsy and trigeminal
neuralgia, exists in four polymorphic forms and as a hydrate (2–4). Physical stresses ap-
plied during manufacturing, like milling, affect transition of one crystalline form to an-
other. One of the most common causes of habit modification is the presence of impuri-
ties in the crystallization solution. The presence of small amounts of an effective additive
in the crystallization medium can dramatically change the crystal size and shape. There
are several reports of changing the crystal habit or polymorphism in the presence of im-
purities during crystallization of carbamazepine (2). The objective of this study was to
achieve improved physicomechanical properties of carbamazepine powder through re-
crystallization from aqueous solutions at different pH values.
EXPERIMENTAL
Materials
Carbamazepine was provided by Arastoo Co. (Tehran, Iran). All the chemicals were
of analytical grade (Merck, Germany).
Spectrophotometric analysis
The spectrophotometeric analysis of carbamazepine samples in phosphate buffer
(pH = 7.4) was performed at 285.8 nm (UV/visible spectrophotometer, Shimadzu-120,
Japan). Standard curves were constructed by serially diluting an aqueous stock solution
of the drug to obtain concentrations in the range of 0.8–40 mg mL–1 using phosphate
buffer as the diluent. Each sample was analyzed in triplicate.
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Buffer preparation
KCl and HCl were used for preparation of medium with pH = 1. Buffer pH = 7 was
prepared from K2HPO4 and NaOH. Boric acid, KCl and NaOH were used for pH = 11
buffer.
Crystallization procedure
Carbamazapine was recrystallized from aqueous solutions at different pH values (1,
7 and 11). Saturated solutions of carbamazepine in water of different pH values were
prepared by dissolving 3 g carbamazepine in 90 mL of appropriate medium at 80 °C.
Saturated solutions were filtered through Milipore filter with pore size less than 0.45 mm
and the filtrates were kept in a fridge at 8 °C for a period of 48 h. The precipitated crys-
tals were filtered off and collected after 48 h using a sintered glass funnel under vac-
uum. The crystals were spread out on a Petri dish, air-dried overnight and further dried
over phosphorous pentoxide in a vacuum oven, at room temperature (25 ± 2 °C) for 2
days. The crystals were stored in a desiccator at room temperature before use.
Flowability test
Flow properties of the powders were evaluated by determining the angle of repose.
Static angle of repose was measured according to the fixed funnel and freestanding cone
method. A funnel with the end of the stem cut perpendicularly to the axis of symmetry
was secured with its tip 10 cm high, H, above graph paper placed on a flat horizontal
surface. The crystals (about 50 g) were carefully poured through the funnel until the
apex of the conical pile so formed just reached the tip of the funnel. The mean diameter
2R, of H, the base of the crystal cone, was determined and the tangent of the angle of re-
pose was given by:
tan a = H/R
where a is the repose angle. Data obtained were the mean and standard deviations of at
least 10 determinations.
Scanning electron microscopy (SEM)
The morphology of crystals was examined with a scanning electron microscope
(Leica Cambridge S360, UK) operating at 15 kV. The samples were mounted on a metal
stub with double adhesive tape and coated under vacuum with gold in an argon atmo-
sphere prior to analysis.
X-ray powder diffraction (XRPD)
The cavity of the metal sample holder of an X-ray diffractometer was filled with
ground sample powder and then smoothed with a spatula. X-ray diffraction patterns of
carbamazepine samples were obtained using the X-ray diffractometer (Siemens, D5000,
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Germany) at 40 kV, 30 mA and a scanning rate of 0.06° min–1 over the range 5–50 2q, us-
ing CuKa1 radiation of wavelength 1.5405 ´ 10–10 m.
Differential scanning calorimetery (DSC)
After calibration with indium and lead standards, samples of carbamazepine crys-
tals were heated (range 25–200 °C) at 10 °C min–1 in crimped aluminium pans using a
DSC instrument (Shimadzu DSC 60, Japan) under a nitrogen atmosphere.
Preparation of compacts of carbamazepine crystals
Crystals were ground using a mortar and pestle to achieve similar particle size dis-
tribution (90–250 mm) for each batch. Compacts were prepared directly from the ground
crystals using 8-mm flat-faced punches on a hydraulic press (Riken, Japan). The material
for each tablet was weighed, introduced into the die and compacted under various com-
pression pressures. Compaction surfaces were lubricated with 1 % (m/m) magnesium
stearate in acetone before compaction. The compacts were held under load for 30 s, ejec-
ted and stored in screw-capped bottles for 24 h before use to allow for possible harden-
ing and elastic recovery.
Tablet crushing strength
The force required to fracture the compacts on a motorized tablet hardness tester
(Erweka, Germany) was measured to determine the tablet crushing strength. The results
are the mean and standard deviations of minimum six determinations.
Dissolution studies
A USP dissolution test apparatus No. 2 (Erweka DPT6R, Germany) (2) was used to
monitor the dissolution profiles of carbamazepine powder. The dissolution medium was
900 mL phosphate buffer (pH = 7.4) equilibrated to 37 °C. The paddles were rotated at
50 rpm. From the dissolution flask 5-mL samples were withdrawn at selected time inter-
vals and the concentration of carbamazepine in the samples was determined at 285.8 nm.
At least three determinations per sample were carried out. As the dissolution rate could
be affected by particle size, the mean particle size of 350 mm (250–450 mm) obtained by
the sieving technique was chosen for dissolution studies of samples.
The in vitro release profiles of different carbamazepine formulations were compared
using similarity factors, f2, as defined by the following equation (5):
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where n is the number of time points at which percent of dissolved drug was determi-
ned, Rt is the % dissolved from the formulation at a given time point and Tt is the % dis-
solved from the formulation for comparison at the same time point. The similarity factor
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fits the result between 0 and 100. It is 100 when the test and reference profiles are identi-
cal and approaches 0 as the dissimilarity increases. An f2 above 50 indicates that the two
profiles are similar.
Statistical analysis
All the data were statistically analyzed by the analysis of variance or Tukey’s multi-
ple comparison test.
RESULTS AND DISCUSSION
Fig. 1 shows the scanning electron micrographs (SEM) of untreated (starting carba-
mazepine obtained from supplier) and treated carbamazepine crystals obtained from
water with different pHs. It is clear from the figure that carbamazepine crystallization in
different media affected the morphology and size of carbamazepine crystals. According
to SEM, the shape of carbamazepine crystals changed from cubic or thin plate-like to
needle-shaped in all recrystallized samples. The crystallization medium pH had no sig-
nificant effect on the crystal shape. Changes in the morphology of carbamazepine crys-
tals could be due to pH alteration or the presence of some additives in the medium. The
figures also show a clear difference in size of the treated crystals in comparison with un-
treated material. It can be concluded that crystallization of carbamazepine from distilled
water at different pH values resulted in larger crystals than that of untreated samples.
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Fig. 1. SEM of carbamazepine: a) untreated and grown in media with pH: b) 1, c) 7 and d) 11.
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XRDP patterns of treated and untreated samples for diffraction angles are shown in
Fig. 2. Carbamazepine has four polymorphic forms and an anhydrous form (6). Form I
has diagnostic peaks at 2q of 7.92, 9.37, 12.28 and 19.99° and form II has diagnostic peaks
at 2q of 8.68, 13.26, 18.56 and 24.54°. The indicative peaks for form III occur at 2q of
15.36, 19.56, 25 and 27.47°. Form IV has characteristic peaks at 2q of 14.11, 17.89, 21.79
and 33.11°. The XRPD of commercial carbamazepine (untreated sample) was identical to
that of form III reference standard and to that reported by the International Centre for
Diffraction Data. The most providing piece of evidence for the existence of form III in
the untreated sample is the absence of peaks between 2q of 2–10° (2, 6). The XRPD spec-
tra of the untreated material and recrystallized samples obtained from water at different
pH showed similar patterns to that of the untreated sample, suggesting that particles
crystallized from water at different pHs did not undergo structural modifications. How-
ever, the presence of very tiny peaks at 2q = 6.1° (form I) and 14.1° (form II) indicates
that these samples contain small amounts of form I and II. This is in agreement with the
results published for forms I and II by Kala et al. (7) and Krahn and Mielck (8). Differ-
ences in relative intensities of the peaks of treated samples may be attributed to the dif-
ferences in crystal sizes and habits of the samples, which may be attributed to the differ-
ent solubility of the drug in crystallization media. Davey (9) reported that changes in
solubility would imply differences in the growth rate of the crystals. It can be concluded
that recrystallization of carbamazepine from media with different pH values caused mi-
nor polymorphic changes.
DSC thermograms of the carbamazepine polymorph form I show no transformation
and melts between 189 and 193 °C (10). Form II does not melt but, instead, a transformation
occurs between 135 and 170 °C and the new phase then melts between 188 and 192 °C.
The large transformational interval is due, in part, to higher initiation temperatures for
crystals with fewer defects, as determined by observing populations of crystals during
heating. Form III melts and crystallizes to a new form almost simultaneously between 162
and 175 °C. The new form subsequently melts between 189 and 193 °C. Form IV shows
melting and partial crystallization to a new form between 178 and 187 °C, significantly
higher than the transition temperatures of forms II or III. This is followed by further cry-
stallization to produce a material that then melts between 190 and 192 °C. Based on the
measured melting point, it appeared that the untreated carbamazepine is form III and
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Fig. 2. XRDP patterns of carba-
mazepine crystals: a) untreated
carbamazepine and that grown
in media with pH: b) 1, c) 7 or
d) 11.
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the recrystallized samples can be mixtures of forms I and II. These findings support the
results obtained by XRPD. It can be concluded that the pH might change the type of
polymorph during crystallization. More studies should be carried out on these samples,
using DSC or other available techniques, to quantify the amount of different poly-
morphs in carbamazepine samples, which was out of the scope of the present study.
The flowability results shown in Table I for carbamazepine crystals were obtained
by measuring the angle of repose. According to the repose angle method, values for an-
gles of repose  30° usually indicate a free-flowing material and angles  40° suggest a
poorly flowing material (11). According to Table I, untreated carbamazepine showed
better flow properties compared to recrystallized materials. The flow properties of a ma-
terial result from a number of forces. Solid particles attract one another and forces acting
between particles when they are in contact are predominately surface forces. There are
many types of forces that can act between solid particles: (i) frictional forces, (ii) surface
tension forces, (iii) mechanical forces caused by interlocking of particles of irregular shape,
(iv) electrostatic forces, (v) cohesive or van der Waals forces. All of these forces can affect
the flow properties of a solid. In case of fine particles ( 150 mm), the magnitude of fric-
tional and van der Waals forces usually predominate. For larger particles ( 150 mm),
frictional forces normally predominate over van der Waals forces. Also, as particles increase
193
Y. Javadzadeh et al.: Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values, Acta
Pharm. 59 (2009) 187–197.
Table I. Repose angles of untreated and recrytallized carbamazepine
Medium Angle of repose (mean ± SD) (º)a
Untreated 16.74 ± 2.42
pH = 1 30.88 ± 1.14
pH = 7 30.76 ± 1.88
pH = 11 30.75 ± 2.05
a n = 10
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–5.00
–10.00
–15.00
Temperature (°C)
DSC
mW untreated carbamazepine
pH = 1
pH = 7.7
pH = 11
Fig. 3. Thermograms of differ-
ent carbamazepine crystals.
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in size, mechanical or physical properties of particles and their packing become impor-
tant. As evident from the Table I, there are no significant differences between recrystalli-
zed materials in different media, but a lower value is obtained in untreated carbama-
zepine and there is a significant difference compared to other materials (p < 0.05), indi-
cating better flowability. This is due to differences in their shapes and sizes. Cubic pow-
ders usually show a better flow rate than needle-shaped ones (12).
Fig. 4 shows the crushing strengths of tablets compressed under different pressures.
Compression of untreated carbamazepine crystals at all compaction pressures produced
weak compacts of low crushing strength. Needle-shaped carbamazepine crystals showed
considerable improvement in compactibility of carbamazepine crystals. The results show
that when the compression pressure increased from 1 to 2 MPa, the crushing strength of
carbamazepine tablets recrystallized at different pHs decreased. It has been shown that
the shape of a crystal is a complex characteristic, and its importance with regard to pow-
der properties is therefore difficult to assess (13). It has been previously shown that various
carbamazepine crystals undergo fragmentation during compression. Compaction of
powders into tablets showed that the particle shape affected compact strength in materi-
als which fragmented to a limited degree during compression. For example, more irreg-
ular particles improved the compactibility (14). However, for materials which frag-
mented markedly during compression, the shape of the particles before compaction did
not affect compact strength. Hence, the effect of particle shape on the compact bonding
characteristics is dependent on the volume reduction properties of the materials. For
materials which fragment to a large extent, the physical structure of the formed compact
is to a limited extent affected by variations in particle shape before compaction. It stands
to reason that with increased particle irregularity the number of possible interparticulate
attraction zones in a compact, and consequently the compact strength, will increase. It is
also possible that during the compression process, the particles can undergo an increa-
sed degree of deformation due to increased particle irregularity at the edges and corners
of the crystals. Increased local particle deformation will lead to an increased bonding
force of the attraction zones between compact particles. These are the reasons for the in-
crease in the crushing strength of compacts made from carbamazepine recrystallized
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material. It has been shown that there is generally an increase in tablet strength with a
decrease in particle size (14). It was also observed that tablet strength is more or less in-
dependent of particle size in case of compacts of aggregated materials (highly fragmen-
ted particles).
Dissolution profiles of untreated and recrystallized carbamazepine are shown in
Fig. 5. As it is clear from the figure, the amount of carbamazepine dissolved from treated
samples was significantly (f2 < 50) higher than untreated carbamazepine. The highest
dissolution rate was observed for the crystals recrystallized in media with pH 1 and 11
and the lowest dissolution rate was observed for untreated carbamazepine. Dissolution
rate of materials could be affected by several factors, including morphology changes, par-
ticle size and adsorption of additives (such as Na+, K+ or PO43–) on the crystal surface. It
was shown (3) that form III of carbamazepine exhibited a rapid increase in dissolution
rate at the initial stage, then the concentration gradually decreased with precipitation of
dehydrated crystals. Also, it was shown that form I starts to dehydrate after 4 h. Crystal
habit and closely related properties, such as particle size, anisotropy, defects and hydro-
dynamic conditions during dissolution are known to influence the dissolution profiles
of crystals. The observed effects have been attributed to the different intrinsic dissolu-
tion rates of different crystal faces whose relative areas differ from habit to habit and
also to their interaction with the solvent involved. It is possible that the presence of some
additives in the crystal growth medium may block the growth of the higher energy sites
of crystal surface, making them less available for active dissolution (2).
CONCLUSIONS
Carbamazepine particles recrystallized from aqueous solutions with different pH
values appear to have superior mechanical properties to the original carbamazepine
sample. This might be due to different morphological structures of carbamazepine sam-
ples. The pH of crystallization medium had a significant effect on the dissolution rate of
carbamazepine powders and samples obtained at pH 11 and 1 showed a higher dissolu-
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tion rate compared to samples (recrystallized at pH 7) and the original carbamazepine
sample.
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S A @ E T A K
Pobolj{anje fizi~ko-mehani~kih svojstava karbamazepina
prekristalizacijom pri razli~itim pH
YOUSEF JAVADZADEH, AMENEH MOHAMMADI, NAZANINOSSADAT SEYED KHOEI i ALI NOKHODCHI
Morfologija kristala ima va`nu ulogu na fizi~ko-mehani~ka svojstva lijekova. Kri-
stalini~nost mo`e utjecati na te~nost, osloba|anje, tvrdo}u i bioraspolo`ivost lijekova. Cilj
ovog rada bio je pobolj{ati fizi~ko-mehani~ka svojstva praha karbamazepina prekristali-
zacijom iz vodenih otopina pri razli~itim pH vrijednostima (1, 7 i 11). Fizi~ko-mehani~ka
svojstva prekristaliziranog karbamazepina odre|ivana su na sljede}i na~in: morfologija
kristala ispitivana je pretra`nom elektronskom mikroskopijom, polimorfi su identifici-
rani rendgenskom difrakcijom praha (XRPD), a termodinami~ka svojstva analizirana su
diferencijalnom pretra`nom kalorimetrijom (DSC). Topljivost je odre|ena pomo}u apa-
rata po USP. Mehani~ka svojstva prekristaliziranog karbamazepina ispitivana su tijekom
tabletiranja pri razli~itim tlakovima i mjerenjem tvrdo}e nastalih tableta. SEM ispitivanja
pokazala su da kristalizacija karbamazepina iz razli~itih medija utje~e na morfologiju i
veli~inu kristala. Oblik kristala mijenjao se od pahuljastog ili plo~astog do igli~astog. XRPD
i DSC metodom mogle su se pratiti promjene u kristalini~nosti nastale zbog promjene
temperature i pH. Mjerenje lomljivosti tableta ukazuje da su svi prekristalizirani uzorci
karbamazepina kompaktniji od polaznog pra{kastog uzorka. Ispitivanja topljivosti in vitro
pokazala su da su kristali dobiveni iz otopine pH 11 i 1 topljiviji. Uzorci karbamazepina
dobiveni prekristalizacijom iz vodenih otopina razli~ite pH vrijednosti imali su bolja
mehani~ka svojstva od originalnog uzorka karbamazepina.
Klju~ne rije~i: karbamazepin, kristalizacija, pH, polimorfizam
Faculty of Pharmacy and Drug Applied Research Centre, Tabriz University of Medical Sciences
Tabriz 51664, Iran
Medway School of Pharmacy, Central Ave., University of Kent and Greenwich, Chatham, Kent
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